Literature DB >> 28781236

Structural Variation of Type I-F CRISPR RNA Guided DNA Surveillance.

Patrick Pausch1, Hanna Müller-Esparza2, Daniel Gleditzsch2, Florian Altegoer1, Lennart Randau3, Gert Bange4.   

Abstract

CRISPR-Cas systems are prokaryotic immune systems against invading nucleic acids. Type I CRISPR-Cas systems employ highly diverse, multi-subunit surveillance Cascade complexes that facilitate duplex formation between crRNA and complementary target DNA for R-loop formation, retention, and DNA degradation by the subsequently recruited nuclease Cas3. Typically, the large subunit recognizes bona fide targets through the PAM (protospacer adjacent motif), and the small subunit guides the non-target DNA strand. Here, we present the Apo- and target-DNA-bound structures of the I-Fv (type I-F variant) Cascade lacking the small and large subunits. Large and small subunits are functionally replaced by the 5' terminal crRNA cap Cas5fv and the backbone protein Cas7fv, respectively. Cas5fv facilitates PAM recognition from the DNA major groove site, in contrast to all other described type I systems. Comparison of the type I-Fv Cascade with an anti-CRISPR protein-bound I-F Cascade reveals that the type I-Fv structure differs substantially at known anti-CRISPR protein target sites and might therefore be resistant to viral Cascade interception.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CRISPR-Cas; Cascade variation; DNA; PAM recognition; R-loop; X-ray crystallography; anti-CRISPR evasion; crRNA; type I-Fv

Mesh:

Substances:

Year:  2017        PMID: 28781236     DOI: 10.1016/j.molcel.2017.06.036

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  20 in total

1.  Structural basis of Type IV CRISPR RNA biogenesis by a Cas6 endoribonuclease.

Authors:  Hannah N Taylor; Emily E Warner; Matthew J Armbrust; Valerie M Crowley; Keith J Olsen; Ryan N Jackson
Journal:  RNA Biol       Date:  2019-06-28       Impact factor: 4.652

Review 2.  Chemistry of Class 1 CRISPR-Cas effectors: Binding, editing, and regulation.

Authors:  Tina Y Liu; Jennifer A Doudna
Journal:  J Biol Chem       Date:  2020-08-14       Impact factor: 5.157

3.  CRISPR Surveillance Turns Transposon Taxi.

Authors:  Tanner Wiegand; Blake Wiedenheft
Journal:  CRISPR J       Date:  2020-02

4.  Structure Reveals a Mechanism of CRISPR-RNA-Guided Nuclease Recruitment and Anti-CRISPR Viral Mimicry.

Authors:  MaryClare F Rollins; Saikat Chowdhury; Joshua Carter; Sarah M Golden; Heini M Miettinen; Andrew Santiago-Frangos; Dominick Faith; C Martin Lawrence; Gabriel C Lander; Blake Wiedenheft
Journal:  Mol Cell       Date:  2019-03-11       Impact factor: 17.970

Review 5.  Structural biology of CRISPR-Cas immunity and genome editing enzymes.

Authors:  Joy Y Wang; Patrick Pausch; Jennifer A Doudna
Journal:  Nat Rev Microbiol       Date:  2022-05-13       Impact factor: 78.297

Review 6.  Evolutionary Ecology and Interplay of Prokaryotic Innate and Adaptive Immune Systems.

Authors:  Tatiana Dimitriu; Mark D Szczelkun; Edze R Westra
Journal:  Curr Biol       Date:  2020-10-05       Impact factor: 10.834

7.  Cryo-EM Structures Reveal Mechanism and Inhibition of DNA Targeting by a CRISPR-Cas Surveillance Complex.

Authors:  Tai Wei Guo; Alberto Bartesaghi; Hui Yang; Veronica Falconieri; Prashant Rao; Alan Merk; Edward T Eng; Ashleigh M Raczkowski; Tara Fox; Lesley A Earl; Dinshaw J Patel; Sriram Subramaniam
Journal:  Cell       Date:  2017-10-05       Impact factor: 41.582

8.  Predicted highly derived class 1 CRISPR-Cas system in Haloarchaea containing diverged Cas5 and Cas7 homologs but no CRISPR array.

Authors:  Kira S Makarova; Svetlana Karamycheva; Shiraz A Shah; Gisle Vestergaard; Roger A Garrett; Eugene V Koonin
Journal:  FEMS Microbiol Lett       Date:  2019-04-01       Impact factor: 2.742

Review 9.  Structural insights into the inactivation of the type I-F CRISPR-Cas system by anti-CRISPR proteins.

Authors:  Lingguang Yang; Yi Zhang; Peipei Yin; Yue Feng
Journal:  RNA Biol       Date:  2021-10-04       Impact factor: 4.766

10.  Repurposing type I-F CRISPR-Cas system as a transcriptional activation tool in human cells.

Authors:  Yuxi Chen; Jiaqi Liu; Shengyao Zhi; Qi Zheng; Wenbin Ma; Junjiu Huang; Yizhi Liu; Dan Liu; Puping Liang; Zhou Songyang
Journal:  Nat Commun       Date:  2020-06-19       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.